Provider: Rapamycin Press LLC dba Impact Journals
TY - JOUR
AU - Cuyà s, Elisabet
AU - Gumuzio, Juan
AU - Verdura, Sara
AU - Brunet, Joan
AU - Bosch-Barrera, Joaquim
AU - Martin-Castillo, Begoña
AU - Alarcón, Tomás
AU - Encinar, José Antonio
AU - Martin, Ãngel G.
AU - Menendez, Javier A.
TI - The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes
JO - Aging
JA - Aging (Albany NY)
VL - 12
IS - 6
PB - Rapamycin Press LLC dba Impact Journals
SN - 1945-4589
UR - https://doi.org/10.18632/aging.102887
DO - 10.18632/aging.102887
SP - 4794
EP - 4814
PY -
ER -